Export (tab separated) Export to Excel
| Disease_Term | Source | Rank | Other Values | Sea-blue histiocyte disease, 269600 (3) | OMIM | high |
|
Lipoprotein glomerulopathy, 611771 (3) | OMIM | high |
|
Hyperlipoproteinemia, type III, 617347 (3) | OMIM | high |
|
Alzheimer disease-2, 104310 (3) | OMIM | high |
|
{?Macular degeneration, age-related}, 603075 (3) | OMIM | high |
|
{Coronary artery disease, severe, susceptibility to}, 617347 (3) | OMIM | high |
|
Cardiovascular disease risk factors | GWAS | high | Alzheimer's disease (age of onset) | GWAS | high |
|
Metabolite levels | GWAS | high | Lipid traits | GWAS | high | Hippocampal atrophy | GWAS | high | Cholesterol, total | GWAS | high | Verbal declarative memory | GWAS | high |
|
Blood metabolite ratios | GWAS | high |
|
Psychosis and Alzheimer's disease | GWAS | high |
|
Alzheimer disease and age of onset | GWAS | high |
|
Longevity (85 years and older) | GWAS | high |
|
LDL cholesterol levels | GWAS | high |
|
Coronary artery disease | GWAS | high | Cerebral amyloid deposition (PET imaging) | GWAS | high |
|
Sphingolipid levels | GWAS | high | Alzheimer's disease (late onset) | GWAS | high | Metabolite levels (lipoprotein measures) | GWAS | high |
|
Cingulate cortical amyloid beta load | GWAS | high |
|
Very long-chain saturated fatty acid levels (fatty acid 20:0) | GWAS | high |
|
Body fat percentage | GWAS | high |
|
Quantitative traits | GWAS | high |
|
Longevity (90 years and older) | GWAS | high | Lewy body disease | GWAS | high |
|
C-reactive protein | GWAS | high | Cerebral amyloid deposition positivity (PET imaging) | GWAS | high |
|
Triglycerides | GWAS | high |
|
Alzheimer's disease biomarkers | GWAS | high | Advanced age-related macular degeneration | GWAS | high |
|
Lipoprotein-associated phospholipase A2 activity and mass | GWAS | high | Ideal cardiovascular health (clinical) | GWAS | high |
|
Cognitive decline | GWAS | high | Brain imaging | GWAS | high |
|
Response to statins (LDL cholesterol change) | GWAS | high | Alzheimer's disease | GWAS | high |
|
Metabolic syndrome | GWAS | high | Lipid metabolism phenotypes | GWAS | high | HDL cholesterol | GWAS | high |
|
Cerebrospinal AB1-42 levels in Alzheimer's disease dementia | GWAS | high |
|
Type 2 diabetes | GWAS | high |
|
Apolipoprotein Levels | GWAS | high |
|
Posterior cortical atrophy and Alzheimer's disease | GWAS | high |
|
Age-related macular degeneration | GWAS | high | Longevity | GWAS | high | LDL cholesterol | GWAS | high |
|
Cognitive decline (age-related) | GWAS | high |
|
|---|